Effective inhibition of Clostridioides difficile by the novel peptide CM-A.
Clostridioides difficile infection is the most common cause of nosocomial and antibiotic-associated diarrhea. C. difficile treatment is increasingly likely to fail, and the recurrence rate is high. Antimicrobial peptides are considered an alternative treatment for many infectious diseases, including...
Guardado en:
Autores principales: | Sirirak Arthithanyaroj, Surang Chankhamhaengdecha, Urai Chaisri, Ratchaneewan Aunpad, Amornrat Aroonnual |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe207abfbfb442eaa7f132fa99f6e14b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epidemiology of Clostridioides difficile in South Africa.
por: Pieter de Jager, et al.
Publicado: (2021) -
Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.
por: Alexis Fong, et al.
Publicado: (2021) -
Faecal transplantation and Clostridioides difficile infection
por: Knežević Darija A., et al.
Publicado: (2021) -
Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence.
por: Megan G Taggart, et al.
Publicado: (2021) -
High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro
por: Rusha Pal, et al.
Publicado: (2021)